Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 270
Filter
1.
Int. j. morphol ; 41(3): 894-900, jun. 2023. ilus, tab
Article in English | LILACS | ID: biblio-1514321

ABSTRACT

SUMMARY: It is known that diabetes mellitus has late complications, including microvascular and macrovascular diseases. Diabetes can affect bones through biochemical markers of bone structure, density, and turnover. This study aimed to biomechanically investigate the bone-protective effects of angiotensin 1-7 (Ang 1-7), one of the active peptides in the renin-angiotensin system, in rats with diabetes. Thirty male Wistar albino rats, three months old and weighing 250-300 g, were divided into four groups: diabetes, Ang 1- 7, diabetes plus Ang 1-7, and control. One month later, diabetes developed in rats; the rats were sacrificed, and their right femur was removed. Three-point bending biomechanical tests were performed on the femurs. The diabetic group had significantly higher bone fragility than the other groups (Pr >.05). Bone fragility was lower, and bone flexibility was higher in the Ang 1-7 groups (Pr>F value 0.05). As a result of our study, the effect of Ang 1-7 on the bones of rats with diabetes was investigated biomechanically. Ang 1-7 has a protective impact on the bones of rats with diabetes.


Se sabe que la diabetes mellitus tiene complicaciones tardías, incluyendo enfermedades microvasculares y macrovasculares. La diabetes puede afectar los huesos a través de los marcadores bioquímicos de la estructura, la densidad y el recambio óseo. Este estudio tuvo como objetivo investigar biomecánicamente los efectos protectores en los huesos de la angiotensina 1-7 (Ang 1-7), uno de los péptidos activos en el sistema renina-angiotensina, en ratas con diabetes. Treinta ratas albinas Wistar macho, de tres meses de edad y con un peso de 250-300 g, se dividieron en cuatro grupos: diabetes, Ang 1-7, diabetes más Ang 1-7 y control. Un mes después, se desarrolló diabetes en ratas; se sacrificaron los animales y se extrajo su fémur derecho. Se realizaron pruebas biomecánicas de flexión de tres puntos en los fémures. El grupo diabéticos tenía una fragilidad ósea significativamente mayor que los otros grupos (Pr > 0,05). La fragilidad ósea fue menor y la flexibilidad ósea fue mayor en los grupos Ang 1-7 (valor Pr>F 0,05). Como resultado de nuestro estudio, se determinó biomecánicamente el efecto de Ang 1-7 en los huesos de ratas con diabetes. Se concluye que Ang 1-7 tiene un impacto protector en los huesos de ratas diabéticas.


Subject(s)
Animals , Male , Rats , Peptide Fragments/administration & dosage , Renin-Angiotensin System , Angiotensin I/administration & dosage , Diabetes Mellitus, Experimental , Femur/drug effects , Biomechanical Phenomena , Bone and Bones/drug effects , Rats, Wistar , Disease Models, Animal
2.
Article | IMSEAR | ID: sea-219413

ABSTRACT

The short-term effects of garlic, Allium sativum L., on the mRNA expression of angiotensin-1 converting enzyme (ACE), angiotensinogen (AGT), and atrial natriuretic peptide (ANP) in cyclosporine-induced prehypertensive rats were investigated in this work. Seven (7) groups of animals totaling n=7 were created. Prehypertensive (induced with 25mg/kg cyclosporine) and normal rats were given 10% and 20% diets based on garlic for 7 days. Alteration of Na+ and K+ levels, increased systolic and diastolic blood pressures, and ACE, AGT & ANP mRNA expressions were all associated with cyclosporin-induced prehypertension. In rats placed on garlic-based diets, these effects were reversed.

3.
Int. j. morphol ; 41(2): 675-685, abr. 2023. ilus, tab
Article in English | LILACS | ID: biblio-1440334

ABSTRACT

SUMMARY: Pulmonary ventilation is a mechanical process in which the respiratory muscles act in coordination to maintain the oxygenation of the organism. Any alteration in the performance of these muscles may reduce the effectiveness of the process. The respiratory muscles differ from the other skeletal muscles in the vital support that they provide through rhythmiccontractions. The structure and energy system of the muscles are specially adapted to perform this function. The composition of the respiratory muscles is exceptional; they are small, and present an abundant capillary network, endowing them with a high aerobic level and resistance to fatigue. Coordinated regulation of the local renin-angiotensin system provides proper blood flow and energy supply in the myofibrils of the skeletal muscle tissue. Specifically, this performance will depend to a large extent on blood flow and glucose consumption, regulated by the renin-angiotensin system. The angiotensin converting enzyme is responsible for degrading kinins, which finally regulate muscle bioenergy and glucose between the blood vessel and the skeletal muscle. The objective of this review is to describe the structure of the respiratory muscles and their association with the angiotensin converting enzyme gene.


La ventilación pulmonar es un proceso mecánico en el que los músculos respiratorios actúan coordinadamente para mantener la oxigenación en el organismo. Así, cualquier alteración en el desempeño de estos músculos puede reducir la efectividad del proceso. Los músculos respiratorios se diferencian de otros músculos esqueléticos, debido al apoyo vital que brindan a través de sus contracciones rítmicas. La estructura y el sistema energético de estos músculos están especialmente adaptados para realizar esta función. La composición de los músculos respiratorios es especial; son pequeñas y presentan una abundante red capilar, lo que les otorga un alto nivel aeróbico y resistencia a la fatiga. La regulación coordinada del sistema renina-angiotensina local, proporciona un adecuado flujo sanguíneo y suministro de energía a las miofibrillas del músculo esquelético. En concreto, este rendimiento dependerá en gran medida del flujo sanguíneo y del consumo de glucosa, regulado por el sistema renina-angiotensina. Aquí, la enzima convertidora de angiotensina es responsable de degradar las kininas, que finalmente regulan la bioenergía muscular y la glucosa entre el vaso sanguíneo y el músculo esquelético. El objetivo de esta breve comunicación es describir la estructura de los músculos respiratorios y su asociación con el gen de la enzima convertidora de angiotensina.


Subject(s)
Humans , Respiratory Muscles/anatomy & histology , Respiratory Muscles/enzymology , Respiratory Muscles/physiology , Polymorphism, Genetic , Renin-Angiotensin System , Respiratory Muscles/embryology , Peptidyl-Dipeptidase A/genetics
4.
Chinese Journal of Endocrine Surgery ; (6): 80-83, 2023.
Article in Chinese | WPRIM | ID: wpr-989900

ABSTRACT

Objective:To investigate the relationship between renin-angiotensin system (RAS) and bone mineral density in children with glucocorticoids-induced osteoporosis (GIOP) .Methods:From Apr. 2020 to May. 2021, 53 children with GIOP were recruited in the Children’s Hospital of Taiyuan Maternal and Child Health Hospital and included in the observation group, and 47 children who received glucocorticoid therapy but did not suffer from GIOP were included in the control group. The levels of serum RAS components and bone mineral density of the two groups of pediatric patients were detected and compared, and the risk clinical indicators affecting bone mineral density and GIOP were analyzed.Results:There were no significant differences between the observation group and the control group in terms of gender, age, BMI, disease type, type of glucocorticoid use, use of anti-osteoporosis (OP) drugs, expression levels of Angiotensin converting enzyme 2 (ACE2) or angiotensin II (Ang Ⅱ) (all P>0.05) . The bone density value of the observation group was lower than those of the control group, and the levels of angiotensin converting enzyme (ACE) (1.19±0.23) , angiotensin receptor 1 (AT1R) (1.24±0.24) , angiotensin receptor 2 (AT2R) (1.14±0.17) , and Mas receptor (MasR) (1.11±0.28) were significantly higher than those of the control group (1.00±0.23, 1.00±0.25, 1.00±0.21, 1.00±0.20) , and the differences were statistically significant (all P<0.05) . Pearson analysis showed that bone mineral density was negatively correlated with the levels of ACE ( r=-0.34, P=0.013) , AT1R ( r=-0.41, P=0.002) and AT2R ( r=-0.34, P=0.014) , and stepwise regression model showed that ACE ( t=-2.21, P=0.032) and AT1R ( t=-2.92, P=0.005) were the main factors affecting bone mineral density. Logistic regression model analysis showed that bone mineral density ( OR=0.85, P<0.001) , Ang Ⅱ ( OR=0.53, P=0.041) and AT2R ( OR=2.00, P=0.024) were independent clinical risk factors affecting GIOP (all P<0.05) . Conclusion:RAS components ACE and AT1R are independent risk factors affecting bone mineral density in children with GIOP, and are significantly correlated with bone mineral density in children.

5.
Arq. bras. cardiol ; 120(5): e20220756, 2023. tab, graf
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1429813

ABSTRACT

Resumo Fundamento Embora tenha sido relatado que a dieta de jejum intermitente (JI) tem efeitos positivos na saúde do coração e na melhora da pressão arterial, ainda não foi suficientemente esclarecido como poderia ter esses efeitos positivos.Objetivo: Nosso objetivo foi avaliar os efeitos do JI no sistema nervoso autônomo (SNA) e no sistema renina-angiotensina (SRA), que estão intimamente relacionados à pressão arterial. Métodos Setenta e dois pacientes hipertensos foram incluídos no estudo, e os dados de 58 pacientes foram usados. Todos os participantes jejuaram por cerca de 15-16 horas por 30 dias. Os participantes foram avaliados com monitorização ambulatorial da pressão arterial de 24 horas e eletrocardiograma Holter antes e após o JI; também, amostras de sangue venoso de 5 ml foram coletadas para avaliação dos níveis séricos de angiotensina I (Ang-I) e angiotensina II (Ang-II) e da atividade da enzima conversora de angiotensina (ECA). Para análise dos dados, o valor de p < 0,05 foi aceito como significativo. Resultados Comparado ao pré-JI, observou-se queda significativa nas pressões arteriais dos pacientes no pós-JI. Um aumento na potência de alta frequência (AF) e na raiz quadrada média da soma dos quadrados das diferenças entre intervalos NN adjacentes (RMSSD) foram observados após o protocolo JI (p=0,039, p=0,043). A Ang-II e a atividade da ECA foram menores em pacientes após JI (p=0,034, p=0,004), e níveis decrescentes de Ang-II foram determinados como fatores preditivos para melhora da pressão arterial, como o aumento da potência de AF e RMSSD. Conclusão Os presentes achados de nosso estudo demonstraram uma melhora na pressão arterial e a relação da pressão arterial com resultados positivos, incluindo VFC, atividade da ECA e níveis de Ang-II após o protocolo JI.


Abstract Background Although it has been reported that the intermittent fasting (IF) diet has positive effects on heart health and improvement in blood pressure, it has not been sufficiently clarified how it could have these positive effects yet. Objective We aimed to evaluate the effects of IF on the autonomic nervous system (ANS) and renin-angiotensin system (RAS), which are closely related to blood pressure. Methods Seventy-two hypertensive patients were included in the study, and the data of 58 patients were used. All the participants fasted for about 15-16 hours for 30 days. Participants were evaluated with 24-hour ambulatory blood pressure monitoring and Holter electrocardiography before and after IF; also, 5 ml venous blood samples were taken for assessment of Serum angiotensin I (Ang-I) and angiotensin II (Ang-II) levels and angiotensin-converting enzyme (ACE) activity. For data analysis, the p-value <0.05 was accepted as significant. Results Compared to pre-IF, a significant decrease was observed in the patients' blood pressures in post-IF. An increase in high-frequency (HF) power and the mean root square of the sum of squares of differences between adjacent NN intervals (RMSSD) were observed after the IF protocol (p=0.039, p=0.043). Ang-II and ACE activity were lower in patients after IF (p=0.034, p=0.004), and decreasing Ang-II levels were determined as predictive factors for improvement of the blood pressure, like the increase in HF power and RMSSD. Conclusion The present findings of our study demonstrated an improvement in blood pressure and the relationship of blood pressure with positive outcomes, including HRV, ACE activity, and Ang-II levels after the IF protocol.

6.
Arch. endocrinol. metab. (Online) ; 67(6): e000643, Mar.-Apr. 2023. graf
Article in English | LILACS-Express | LILACS | ID: biblio-1447271

ABSTRACT

ABSTRACT Objective: The incidence of diabetic nephropathy (DN) is gradually increasing worldwide. Podocyte injury, such as podocyte apoptosis and loss of the slit diaphragm (SD)-specific markers are early pathogenic features of DN. Materials and methods: The cultured mouse podocytes were separated into a high glucose-treated (HG, 30mM) group to mimic DN in vitro, a low glucose-treated (LG, 5mM) group as a control and HG+ angiotensin-(1-7)(Ang-(1-7)) and HG+Ang-(1-7) + D-Ala7-Ang-(1-7) (A779, Ang-(1-7)/Mas receptor antagonist) experimental groups. The Cell Counting Kit-8 (CCK-8) method and flow cytometry was used to detect podocyte activity and podocyte apoptosis respectively. The expression of angiotensin type 1 receptor (AT1R), Mas receptor (MasR) and podocyte-specific markers were examined by q-PCR and Western blot, respectively. Results: The results showed that the decrease in podocyte activity; the increase in podocyte apoptosis; the decreased mRNA and protein expression of nephrin, podocin, WT-1 and MasR; and the upregulated expression of AT1R induced by HG could be reversed by Ang-(1-7). However, these effects were blocked by A779. The possible mechanisms of the Ang-(1-7)-mediated effect depended on MasR. In addition, the protective effect of Ang-(1-7) on podocyte activity was dose-dependent and most obvious at 10 µM. A779 had the greatest antagonistic action against Ang-(1-7) at a concentration of 10 μM. Conclusion: This study reveals that binding of Ang-(1-7) to its specific receptor MasR may counteract the effects of Ang II mediated by AT1R to significantly attenuate podocyte injury induced by high glucose. Ang-(1-7)/MasR targeting in podocytes may be a therapeutic approach to attenuate renal injury in DN.

8.
China Pharmacy ; (12): 1617-1621, 2023.
Article in Chinese | WPRIM | ID: wpr-977852

ABSTRACT

OBJECTIVE To explore the efficacy of alfacalcidol combined with conventional antihypertensive and lipid- lowering drugs on liver and kidney function, serum inflammatory cytokines and renin-angiotensin system(RAS) in hypertensive patients with renal impairment. METHODS A total of 200 hypertensive patients with renal impairment who were treated in the department of nephrology in our hospital from December 2017 to December 2020 were selected and randomly divided into control group and observation group, with 100 cases in each group. Both groups of patients were treated with conventional antihypertensive and lipid-lowering drugs for a total of 14 weeks, patients in the observation group were additionally treated with oral alfacalcidol after 2 weeks of treatment (0.25 μg each time, once a day, for a total of 12 weeks). The levels of liver function indexes [aspartate aminotransferase (AST), alanine aminotransferase (ALT)], renal function indexes [blood calcium, blood phosphorus, blood urea nitrogen (BUN), cystatin C (Cys-C), serum creatinine (Scr), urine microalbumin (mAlb), β2-microglobulin (β2-MG), urinary N- acetyl β-D-glucosaminidase (NAG), 24 h urinary protein], inflammatory factors [serum interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), hypersensitive C-reactive protein (hs-CRP)] and RAS activity indexes [renin, angiotensin Ⅰ(Ang Ⅰ), Ang Ⅱ and aldosterone] were observed in 2 groups before and after treatment, and the occurrence of adverse drug reactions was recorded during treatment. RESULTS There was no statistical significance in the levels of detection indexes between 2 groups before treatment (P>0.05). After treatment, the level of blood calcium in the observation group was significantly higher than before treatment (P<0.05), but remained at clinically normal level. Compared with before treatment, the levels of Cys-C, Scr, BUN, urine mAlb, β2-MG, NAG and 24 h urinary protein, hs-CRP, IL-6, TNF-α, renin, Ang Ⅰ, Ang Ⅱ and aldosterone were significantly decreased in the observation group after treatment (P<0.05). After treatment, the level of blood calcium in observation group was significantly higher than control group (P<0.05). Additionally, the levels of Cys-C, Scr, BUN,urine mAlb, β2-MG, NAG, 24 h urinary protein, hs-CRP, IL-6, TNF-α, renin, Ang Ⅰ, Ang Ⅱ and aldosterone were significantly lower than control group (P<0.05). There was no statistical significance in the incidence of adverse drug reactions between 2 groups during treatment (P>0.05). CONCLUSIONS Alfacalcidol combined with routine therapy of antihypertensive and lipid-lowering drugs could effectively improve liver and renal functions, inhibit inflammation and RAS activity in hypertensive patients with renal impairment, with a favorable safety.

9.
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 242-248, 2023.
Article in Chinese | WPRIM | ID: wpr-976559

ABSTRACT

Diabetic nephropathy (DN) is a common clinical complication of diabetes, the main cause of end-stage renal disease (ESRD), and a key determinant of survival in diabetic patients. The pathogenesis of DN is complex, and it is currently believed to be associated with hemodynamic abnormalities, intestinal flora disturbances, glucose and lipid metabolism disorders, oxidative stress, genetic susceptibility, and protein non-enzymatic glycosylation. The local renin-angiotensin system (RAS) has always been the core of the pathogenic and progressive changes of DN. Once activated, it will induce the massive release of oxygen free radicals in the blood vessels, damage the endothelial function, and affect the microcirculation of the body. The recent studies demonstrate that intestinal flora and its metabolites may affect the occurrence and development of DN by activating or antagonizing the local RAS. Compared with western medicine treatment, traditional Chinese medicine (TCM) has the advantages of multiple targets and little toxic and side effects. Many TCM scholars have found that single herbs, their active ingredient extracts, and TCM compound prescriptions can improve kidney function by regulating the local RAS or intestinal flora. Specifically, the Chinese medicinal materials tonifying spleen (Codonopsis Radix, Dioscoreae Rhizoma, Atractylodis Macrocephalae Rhizoma, and Poria), replenishing kidney (Rehmanniae Radix Praeparata, Corni Fructus, and Pseudostellariae Radix), and activating blood, resolving stasis, and dredging collaterals (Hirudo, Salviae Miltiorrhizae Radix et Rhizoma, and Angelicae Sinensis Radix) have the regulatory effect. This article summarizes the roles of intestinal flora and local RAS in the occurrence and development of DN, and analyzes the animal experiments or clinical trials of TCM intervention in DN in recent years, aiming to provide more therapies and a theoretical basis for the treatment of DN with integrated TCM and Western medicine.

10.
Chinese Journal of Physical Medicine and Rehabilitation ; (12): 673-677, 2023.
Article in Chinese | WPRIM | ID: wpr-995231

ABSTRACT

Objective:To observe any effect of high-intensity interval training on the blood pressure and renal function of Wistar-Kyoto rats modeling spontaneous hypertension (SHR) and to explore the mechanism of the renal renin-angiotensin system′s (RAS′s) role in this process.Methods:Twenty male SHR were randomly divided into a sedentary group and an exercise group, each of 10. Another 10 Wistar-Kyoto rats formed a normotensive control group. The rats in the normotensive and hypertensive sedentary groups were fed quietly in their cage, while the hypertensive exercise group performed high-intensity interval training for 8 weeks. After the last exercise, blood pressure, renal function, the kidney levels of nitric oxide and interleukin-6 (IL-6) and the protein expressions of angiotensin converting enzyme (ACE), ACE2, angiotensin type 1 receptor (AT1R), AT2R and Mas receptor (MasR) were measured.Results:Compared with the normotensive group, the hypertensive sedentary group showed a significant increase in average blood pressure, IL-6, ACE and AT1R protein and the ratio of AT1R to AT2R. There was a significant decrease in the renal function, the average NO level and the expression of ACE2, AT2R and MasR protein. That group also showed a significant decrease in blood pressure, IL-6, ACE and AT1R protein expression and the AT1R: AT2R ratio compared with the hypertensive sedentary group, but a significant increase in renal function, average NO content and the expression of ACE2, AT2R and MasR protein.Conclusion:Eight weeks of high-intensity interval training has a protective effect on the kidneys by regulating the renin-angiotensin system, at least in rats.

11.
Indian J Physiol Pharmacol ; 2022 Sept; 66(3): 157-167
Article | IMSEAR | ID: sea-223951

ABSTRACT

Objectives: The effects of early renin-angiotensin system (RAS) blockade using angiotensin-converting enzyme (ACE) inhibitor lisinopril and/or angiotensin receptor blocker valsartan on renal nephrin and vascular endothelial growth factor (VEGF)-A gene expression were investigated in diabetic-hypertensive rats. Materials and Methods: Diabetes and hypertension were induced in adult Wistar rats using streptozotocin (45 mg/kg, i.p.) and N?-nitro-L-arginine methyl ester (60 mg/kg/12 h) for 4 consecutive days. Experimental animals were allocated into six groups (n = 6): normal control, diabetic control, diabetic-hypertensive control and lisinopril-, valsartan- and combination-treated diabetic-hypertensive groups (5 mg/kg/drug/day, p.o., for 21 days). Blood glucose, blood pressure, body weight, kidney weight to body weight ratio, serum albumin, creatinine, total protein and urea were measured and recorded every week. Nephrin and VEGF-A gene expression were measured using real-time polymerase chain reaction. Renal nephrin protein was measured using ELISA as well as nephrin immunostaining. Results: Blood pressure was significantly decreased by all treatments (P ? 0.05). All treatments normalised serum albumin and urea. Serum creatinine significantly decreased, while total protein significantly increased (P ? 0.05). Nephrin gene expression had a non-significant decrease in diabetic-hypertensive rats, yet it was statistically increased with individual treatments (P ? 0.05) and normalised with combined treatment. Renal nephrin protein significantly decreased in diabetic-hypertensive rats, normalised by lisinopril and significantly increased by valsartan and combined treatments (P ? 0.05). VEGF-A expression significantly increased in diabetic-hypertensive rats and significantly decreased with lisinopril and valsartan monotherapy and normalised with combined treatment (P ? 0.05). Immunostaining of nephrin also showed an obvious increase in the case of combined treatment. Conclusion: Early dual blockade of RAS in diabetic-hypertensive rats protected against renal damage and improved renal nephrin and VEGF-A gene expression as well as renal nephrin protein expression.

12.
Rev. bras. ginecol. obstet ; 44(7): 710-718, July 2022. tab, graf
Article in English | LILACS | ID: biblio-1394810

ABSTRACT

Abstract Objective To describe the effects of combined oral contraceptives (COC) on the renin-angiotensin-aldosterone system (RAAS). Data sourcesThis is a systematic review according to the criteria of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), registered in PROSPERO under the ID: CRD42020200019. Searches were performed between August 2020 and December 2021, in the following databases: Medline via Pubmed, Cochrane Central Library, Scientific Electronic Library Online, and Latin American and Caribbean Literature in Health Sciences via Virtual Health Library. The effects of the combined oral contraceptive on plasma renin activity values, plasma renin values, angiotensinogen values— also known as plasma renin substrate— angiotensin, and/or aldosterone values. Study selectionA total of 877 studies were selected and, of these, 10 articles met the eligibility criteria and were included in this review. Data collectionData were combined through qualitative synthesis and included in a spreadsheet previously prepared by the authors. Data synthesisThe collected samples ranged from 18 to 137 participants, totaling 501 women aged between 18 and 49 years throughout all studies. The studies showed increased activity of plasma renin, plasma renin substrate, angiotensin II, and aldosterone in this population. Conclusion The findings of this study suggest that the COC promotes greater activation of the RAAS. Supporting the idea that its use is related to an increased risk of cardiovascular events, including systemic arterial hypertension.


Resumo Objetivo Descrever os efeitos do contraceptivo oral combinado (COC) no sistema renina-angiotensina-aldosterona (SRAA). Fontes dos dadosTrata-se de uma revisão sistemática de acordo com os critérios do Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), registrada no PROSPERO sob ID: CRD42020200019. As buscas foram realizadas entre agosto de 2020 e dezembro de 2021 nas bases de dados: Medline via Pubmed, Biblioteca Cochrane Central, Scientific Electronic Library Online, e Literatura Latino-americana e do Caribe em Ciências da Saúde via Biblioteca Virtual em Saúde. Consultado os artigos sobre os efeitos do contraceptivo oral combinado nos valores da atividade da renina plasmática, valores plasmáticos da renina, valores do angiotensinogênio - também conhecido como substrato da renina plasmática -, valores da angiotensina e/ou aldosterona. Seleção dos estudosForam selecionados 877 estudos e, destes, 10 artigos preencheram os critérios de elegibilidade e foram incluídos nesta revisão. Coleta de dadosOs dados foram combinados por meio de síntese qualitativa e inclusos em uma planilha elaborada previamente pelos autores. Síntese dos dadosAs amostras coletadas variavam entre 18 e 137 participantes, totalizando 501 mulheres com idade entre 18 e 49 anos em todos os estudos. Os estudos apresentaram aumento da atividade da renina plasmática, do substrato da renina plasmática, da angiotensina II e da aldosterona nessa população. Conclusão Os achados deste estudo sugerem que o COC promove maior ativação do SRAA. Apoiando a ideia de que o seu uso esteja relacionado ao aumento do risco de eventos cardiovasculares, incluindo a hipertensão arterial sistêmica.


Subject(s)
Humans , Female , Contraceptive Agents, Female
13.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1412782

ABSTRACT

Introducción. El síndrome de Alport es una alteración heterocigótica que afecta las cadenas alfas del colágeno tipo IV, manifestándose clínicamente de forma variable principalmente por hematuria persistente. Existen diferentes manifestaciones clínicas en esta patología, encontrando casos de enfermedad renal crónica. Es crucial establecer medidas que permitan la detección oportuna disminuyendo las complicaciones. Objetivo. Describir la relación e importancia entre el síndrome de Alport y las alteraciones renales, resaltar las manifestaciones clínicas y manejo terapéutico. Métodos. Se realizó una búsqueda de la literatura en las bases de datos de PubMed y Scielo orientada hacia artículos actualizados y relevantes en inglés o español publicados en los últimos 5 años. Se evaluó a relación entre el síndrome de Alport y la patología renal permitiendo describir importancia clínica, diagnóstico y tratamiento. Resultados. Diferentes estudios evidencian la relación directa entre el síndrome de Alport y la disfunción renal asociado a procesos inflamatorios crónicos. El tratamiento no está estandarizado, pero se encuentra dirigido al bloqueo del sistema renina-angiotensina aldosterona. Se deben continuar los estudios evaluando el desenlace de la afectación renal asociada a esta patología. Conclusiones. El síndrome de Alport es una causa importante de disfunción renal, primordialmente si no se asocia a un tratamiento; por lo cual, es importante realizar un diagnóstico oportuno mediante la sospecha inicial, diagnóstico diferencial y abordaje adecuado partiendo del reconocimiento clínico de esta entidad asociada con el deterioro de la función renal


Introduction. Alport syndrome is a heterozygous alteration that affects the alpha chains of type IV collagen, manifesting itself clinically in a variable manner, mainly by persistent hematuria. There are different clinical manifestations in this pathology, fnding cases of chronic renal disease. It is crucial to establish measures that allow timely detection, thus reducing complications. Objective. To describe the relationship and importance between Alport syndrome and renal alterations, highlight the clinical manifestations and therapeutic management. Methods. A literature search was performed in PubMed and Scielo databases oriented towards updated and relevant articles in English or Spanish published in the last 5 years. The relationship between Alport syndrome and renal pathology was evaluated to describe clinical signifcance, diagnosis and treatment. Results. Different studies show a direct relationship between Alport syndrome and renal dysfunction associated with chronic inflammatory processes. The treatment is not standardized, but is aimed at blocking the renin-angiotensin-aldosterone system. Studies should continue to evaluate the outcome of renal involvement associated with this pathology. Conclusions. Alport syndrome is an important cause of renal dysfunction, especially if it is not associated with treatment; therefore, it is important to make a timely diagnosis through initial suspicion, differential diagnosis and appropriate approach based on the clinical recognition of this entity associated with the deterioration of renal function


Introdução. A síndrome de Alport é uma desordem heterozigótica que afeta as cadeias alfa do colágeno tipo IV. afeta as cadeias alfa do colágeno tipo IV, manifestando-se clinicamente de forma variável, principalmente pela hematúria persistente. Existem diferentes manifestações clínicas desta patologia, incluindo casos de doença renal crônica. É crucial estabelecer medidas que permitam a detecção oportuna e reduzam as complicações. Objetivo. Para descrever a relação e a importância entre a síndrome de Alport e as alterações renais, destacar as manifestações clínicas e o manejo terapêutico. Métodos. Foi realizada uma pesquisa bibliográfica nas bases de dados PubMed e Scielo, orientada para artigos atualizados e relevantes em inglês ou espanhol publicados nos últimos 5 anos. A relação entre a síndrome de Alport e a patologia renal foi avaliada para descrever seu significado clínico, diagnóstico e tratamento. Resultados. Diferentes estudos mostram uma relação direta entre a síndrome de Alport e as disfunções renais associadas aos processos inflamatórios crônicos. O tratamento não é padronizado, mas visa bloquear o sistema renina-angiotensina aldosterona. Outros estudos devem continuar a avaliar o resultado do envolvimento renal associado a esta patologia. Conclusões. A síndrome de Alport é uma causa importante de disfunção renal, especialmente se não associada ao tratamento; portanto, é importante fazer um diagnóstico oportuno através da suspeita inicial, diagnóstico diferencial e abordagem apropriada baseada no reconhecimento clínico desta entidade associada à função renal prejudicada

14.
J. bras. nefrol ; 44(1): 19-25, Jan-Mar. 2022. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1365037

ABSTRACT

Abstract Introduction: Studies have shown that the renin angiotensin aldosterone system (RAAS) and inflammation are related to kidney injury progression. The aim of this study was to evaluate RAAS molecules and chemokine (C-C motif) ligand 2 (CCL2) in 82 patients with chronic kidney disease (CKD). Methods: Patients were divided into two groups: patients diagnosed with CKD and patients without a CKD diagnosis. Glomerular filtration rate (GFR) and albumin/creatinine ratio (ACR) were determined, as well as plasma levels of angiotensin-(1-7) [Ang-(1-7)], angiotensin-converting enzyme (ACE)1, ACE2, and plasma and urinary levels of CCL2. Results: CCL2 plasma levels were significantly higher in patients with CKD compared to the control group. Patients with lower GFR had higher plasma levels of ACE2 and CCL2 and lower ratio ACE1/ACE2. Patients with higher ACR values had higher ACE1 plasma levels. Conclusion: Patients with CKD showed greater activity of both RAAS axes, the classic and alternative, and higher plasma levels of CCL2. Therefore, plasma levels of RAAS molecules and CCL2 seem to be promising prognostic markers and even therapeutic targets for CKD.


Resumo Introdução: Estudos têm mostrado que o sistema renina angiotensina aldosterona (SRAA) e a inflamação estão relacionados à progressão da lesão renal. O objetivo deste estudo foi avaliar moléculas do SRAA e o Ligante 2 de Quimiocina com Motivo C-C (CCL2) em 82 pacientes com doença renal crônica (DRC). Métodos: Os pacientes foram divididos em dois grupos: pacientes diagnosticados com DRC e pacientes sem diagnóstico de DRC. Foram determinadas a taxa de filtração glomerular (TFG) e a relação albumina/creatinina (RAC), assim como os níveis plasmáticos de angiotensina-(1-7) [Ang-(1-7)], enzima conversora de angiotensina (ECA)1, ECA2 e níveis plasmáticos e urinários de CCL2. Resultados: Os níveis plasmáticos de CCL2 foram significativamente mais altos em pacientes com DRC em comparação com o grupo controle. Pacientes com TFG mais baixa apresentaram níveis plasmáticos mais elevados de ECA2 e CCL2 e menor relação ECA1/ECA2. Pacientes com valores de RAC mais altos apresentaram níveis plasmáticos de ECA1 mais elevados. Conclusão: Pacientes com DRC mostraram maior atividade de ambos os eixos do SRAA, o clássico e o alternativo, e níveis plasmáticos mais altos de CCL2. Portanto, os níveis plasmáticos de moléculas do SRAA e CCL2 parecem ser marcadores prognósticos promissores e até mesmo alvos terapêuticos para a DRC.

15.
Hematol., Transfus. Cell Ther. (Impr.) ; 44(1): 26-31, Jan.-Mar. 2022. tab
Article in English | LILACS | ID: biblio-1364890

ABSTRACT

Abstract Introduction Coronavirus disease 2019 (COVID-19) may present with extrapulmonary manifestations, including hematologic changes. Previous studies suggest that severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) can interact with the renin-angiotensin system, ultimately causing increased production of angiotensin II. By reporting the cases of previously healthy young adults diagnosed with a hematologic malignancy after experiencing COVID-19, we raise the hypothesis that the SARS-Cov-2 infection could act as a trigger for leukemogenesis in predisposed individuals. Methods This was a case series performed through extraction of relevant clinical information from the medical records of three patients admitted to our Hematology unit between August 2020 and September 2020. Main Results Considering the relatively rapid development of cytopenias following recovery from COVID-19, it cannot be ruled out that SARS-Cov-2 played a role in leukemogenesis in those patients. Based on previous in vitro studies, the renin-angiotensin system imbalance induced by SARS-CoV-2 could potentially promote in vivo leukemogenesis through several mechanisms. Conclusion Despite the advances in pathophysiological and clinical characterization of COVID-19, the consequences of the pandemic to the incidence of hematologic diseases are still to be elucidated. In this context, future dissection of the status of the local bone marrow renin-angiotensin system in leukemogenesis is a clinically relevant basic research area.


Subject(s)
Humans , Male , Female , Adult , Hematologic Neoplasms , COVID-19 , Renin-Angiotensin System , Leukemia , SARS-CoV-2
16.
China Pharmacy ; (12): 758-763, 2022.
Article in Chinese | WPRIM | ID: wpr-923015

ABSTRACT

The re gulators of renin-angiotensin system (RAS) include renin inhibitors ,angiotensin converting enzyme inhibitors,angiotensin Ⅱ receptor blockers ,angiotensin Ⅱ receptor agonists and angiotensin 1-7. This paper summarizes and analyzes the adjuvant effects of RAS regulators on antitumor drugs by searching the literature published from January 1992 to June 2021. The regulators of RAS can reduce the cardiotoxicity ,hematological toxicity and peripheral neurotoxicity of antitumor drugs , and has renal protective effect ;the regulators of RAS combined with other chemotherapy drugs show favorable effects on promoting chemotherapeutic drugs delivery ,improving anti-angiogenesis and bypass activation of targeted drugs ,enhancing tumor immune response of immune checkpoint inhibitors ,so as to improve therapeutic efficacy of antitumor drugs. The combination of RAS regulators with antitumor drugs is expected to reduce the side effects of antitumor drugs ,enhance its efficacy and improve the prognosis of patients.

17.
Asian Journal of Andrology ; (6): 139-146, 2022.
Article in English | WPRIM | ID: wpr-928531

ABSTRACT

The renin angiotensin system (RAS) appears to influence male fertility at multiple levels. In this work, we analyzed the relationship between the RAS and DNA integrity. Fifty male volunteers were divided into two groups (25 each): control (DNA fragmentation ≤20%) and pathological (DNA fragmentation >20%) cases. Activities of five peptidases controlling RAS were measured fluorometrically: prolyl endopeptidase (which converts angiotensin [A] I and A II to A 1-7), neutral endopeptidase (NEP/CD10: A I to A 1-7), aminopeptidase N (APN/CD13: A III to A IV), aminopeptidase A (A II to A III) and aminopeptidase B (A III to A IV). Angiotensin-converting enzyme (A I to A II), APN/CD13 and NEP/CD10 were also assessed by semiquantitative cytometry and quantitative flow cytometry assays, as were the receptors of all RAS components: A II receptor type 1 (AT1R), A II receptor type 2 (AT2R), A IV receptor (AT4R or insulin-regulated aminopeptidase [IRAP]), (pro)renin receptor (PRR) and A 1-7 receptor or Mas receptor (MasR) None of the enzymes that regulate levels of RAS components, except for APN/CD13 (decrease in fragmented cells), showed significant differences between both groups. Micrographs of RAS receptors revealed no significant differences in immunolabeling patterns between normozoospermic and fragmented cells. Labeling of AT1R (94.3% normozoospermic vs 84.1% fragmented), AT4R (96.2% vs 95.3%) and MasR (97.4% vs 87.2%) was similar between the groups. AT2R (87.4% normozoospermic vs 63.1% fragmented) and PRR (96.4% vs 48.2%) were higher in non-fragmented spermatozoa. These findings suggest that fragmented DNA spermatozoa have a lower capacity to respond to bioactive RAS peptides.


Subject(s)
Humans , Male , Angiotensins , DNA Fragmentation , Insulin , Renin-Angiotensin System/physiology , Spermatozoa
18.
Chinese Journal of Physical Medicine and Rehabilitation ; (12): 673-678, 2022.
Article in Chinese | WPRIM | ID: wpr-958171

ABSTRACT

Objective:To observe the effect of exercise on the renin-angiotensin system (RAS) in the blood and skeletal muscles of rats with chronic heart failure (CHF).Methods:Fifty male Wistar rats were randomly divided into a sedentary control group, an exercise control group, a model sedentary group and a model exercise group. CHF was modelled in the rats of the model sedentary and exercise groups, while those of the sedentary and exercise control groups received a sham operation. The exercise groups performed treadmill exercise for 8 weeks (5 times per week). After the 8 weeks the activity of angiotensin-converting enzyme (ACE) and ACE2 in the plasma and soleus muscle was determined using the fluorescent substrate method. Angiotensin II (AngII) and Ang (1-7) were detected in plasma and the soleus muscle using liquid chromatography. The expression of Ang II type 1 receptor (AT1R) and Mas receptor (MasR) in skeletal muscles was detected using western blotting.Results:Compared with the sedentary control group, there was significantly increased average ACE activity and lower average ACE2 activity in the model sedentary group. There was a significant decrease in the average plasma Ang II content and ACE activity, and a significant increase in the Ang-(1-7)/Ang II ratio in the model exercise group. Compared with the model sedentary group, the average ACE activity and plasma Ang II content was significantly lower in the model exercise group but the average ACE2 activity was significantly higher. Compared with the sedentary control group, the average Ang II content and AT1R protein expression in the soleus muscles had increased significantly in the model sedentary group, and the average expression of MasR protein in the soleus muscles increased significantly in the model exercise group. However, compared with the model sedentary group, the average content of Ang II and the average expression of AT1R protein in the soleus muscles had decreased significantly in the model exercise group and the average Ang-(1-7)/Ang II ratio had increased significantly.Conclusion:Exercise can induce the conversion of RAS from ACE-Ang II-AT1R to ACE2-Ang-(1-7)-MasR after chronic heart failure, at least in rats. The changes in the components of the RAS in the plasma and skeletal muscle differ.

20.
Rev. Pesqui. Fisioter ; 11(3): 544-548, ago.2021. ilus, tab
Article in English, Portuguese | LILACS | ID: biblio-1292368

ABSTRACT

INTRODUÇÃO: Os contraceptivos orais são a forma mais utilizada para o controle de natalidade, chegando a 200 milhões de usuárias desde sua iniciação na década de 1960. Desde 2013, nosso grupo de pesquisa tem apresentado resultados que sugerem que mulheres em uso de Contraceptivos Orais Combinados (COC), e sem outros fatores de risco, apresentam maior valor de proteína C reativa, lipemia pós-prandial, lipoproteína de baixa densidade oxidada e diminuição da sensibilidade insulínica, quando comparadas a suas congêneres sem uso de COC. Recentemente, foi verificado que o uso de COC eleva os valores de renina plasmática em 600%, podendo explicar por que o uso desse fármaco é um fator de risco para o desenvolvimento de hipertensão arterial sistêmica. Apesar de o uso de Contraceptivo Hormonal Injetável (CHI) estar aumentando, não encontramos estudos clínicos que abordassem o tema, demonstrando uma lacuna na literatura científica. OBJETIVO: Comparar os valores de renina plasmática, enzima conversora de angiotensina 1 e aldosterona de mulheres que utilizam CHI com mulheres que não utilizam nenhum contraceptivo à base de hormônio. MÉTODOS: Protocolo de um estudo observacional comparativo de corte transversal, composto por mulheres com idade entre 18 e 30 anos, eutróficas, irregularmente ativas pelo Questionário Internacional de Atividade Física, versão curta, que estão em uso continuado de CHI há pelo menos 6 meses ou que não fazem uso. A amostra será por conveniência, as participantes selecionadas assinarão o termo de consentimento livre e esclarecido. Posteriormente, responderão a um questionário padrão, serão submetidas a um exame físico, e serão encaminhadas para coleta das amostras sanguíneas.


INTRODUCTION: Oral contraceptives are the most widely used form of birth control, reaching 200 million users since its inception in the 1960. Since 2013, our research group has presented results that suggest that women using Combined Oral Contraceptives (COC) and without other risk factors, have a higher value of C-reactive protein, postprandial lipemia, oxidized low-density lipoprotein and decreased insulin sensitivity, when compared to their counterparts without the use of COC. Recently, it was found that the use of COC increases plasma renin values by 600%, which may explain why the use of this drug is a risk factor for the development of systemic arterial hypertension. Although the use of Injectable Hormonal Contraceptives (IHC) is increasing, we have not found clinical studies that addressed the topic, demonstrating a gap in the scientific literature. OBJECTIVE: Compare the values of plasma renin, angiotensin-converting enzyme 1 and aldosterone of women using IHC with women who do not use any hormone-based contraceptives. METHODS: Protocol of a comparative observational cross-sectional study, composed of women aged between 18 and 30 years, eutrophic, irregularly active by the International Physical Activity Questionnaire, short version, who have been in continuous use of IHC for at least 6 months or that do not use. The sample will be for convenience and the selected participants will sign the informed consent form. Subsequently, they will answer a standard questionnaire, undergo a physical examination, and be sent to collect blood samples.


Subject(s)
Renin-Angiotensin System , Women's Health , Hypertension
SELECTION OF CITATIONS
SEARCH DETAIL